Northern Trust’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-498,787
| Closed | -$82.4M | – | 4816 |
|
|
2021
Q2 | $82.4M | Sell |
498,787
-43,639
| -8% | -$7.29M | 0.01% | 775 |
|
|
2021
Q1 | $83.2M | Buy |
542,426
+41,871
| +8% | +$5.69M | 0.02% | 759 |
|
|
2020
Q4 | $62.8M | Sell |
500,555
-5,571
| -1% | -$623K | 0.01% | 909 |
|
|
2020
Q3 | $51.3M | Sell |
506,126
-16,224
| -3% | -$1.65M | 0.01% | 892 |
|
|
2020
Q2 | $50.8M | Buy |
522,350
+9,333
| +2% | +$869K | 0.01% | 884 |
|
|
2020
Q1 | $42.6M | Buy |
513,017
+16,654
| +3% | +$1.62M | 0.01% | 861 |
|
|
2019
Q4 | $55.2M | Sell |
496,363
-528
| -0.1% | -$54.3K | 0.01% | 952 |
|
|
2019
Q3 | $49.3M | Buy |
496,891
+31,886
| +7% | +$3.17M | 0.01% | 988 |
|
|
2019
Q2 | $46.1M | Sell |
465,005
-9,364
| -2% | -$894K | 0.01% | 1057 |
|
|
2019
Q1 | $52.3M | Buy |
474,369
+18,959
| +4% | +$1.98M | 0.01% | 934 |
|
|
2018
Q4 | $41.9M | Buy |
455,410
+6,055
| +1% | +$613K | 0.01% | 993 |
|
|
2018
Q3 | $49.5M | Buy |
449,355
+18,841
| +4% | +$1.96M | 0.01% | 1034 |
|
|
2018
Q2 | $40.2M | Sell |
430,514
-190,430
| -31% | -$16.4M | 0.01% | 1204 |
|
|
2018
Q1 | $51.5M | Sell |
620,944
-3,136
| -0.5% | -$279K | 0.01% | 975 |
|
|
2017
Q4 | $56.8M | Buy |
624,080
+14,093
| +2% | +$1.17M | 0.01% | 889 |
|
|
2017
Q3 | $46.5M | Buy |
609,987
+109,318
| +22% | +$8.26M | 0.01% | 1014 |
|
|
2017
Q2 | $37.6M | Buy |
500,669
+148,153
| +42% | +$10.3M | 0.01% | 1161 |
|
|
2017
Q1 | $23M | Buy |
352,516
+6,275
| +2% | +$370K | 0.01% | 1542 |
|
|
2016
Q4 | $19.1M | Buy |
346,241
+24,451
| +8% | +$1.34M | 0.01% | 1644 |
|
|
2016
Q3 | $18.2M | Buy |
321,790
+10,727
| +3% | +$526K | 0.01% | 1663 |
|
|
2016
Q2 | $13M | Buy |
311,063
+62,242
| +25% | +$2.87M | ﹤0.01% | 1838 |
|
|
2016
Q1 | $10.6M | Buy |
248,821
+11,041
| +5% | +$467K | ﹤0.01% | 1937 |
|
|
2015
Q4 | $10.8M | Buy |
237,780
+5,745
| +2% | +$241K | ﹤0.01% | 1964 |
|
|
2015
Q3 | $9.01M | Buy |
232,035
+14,369
| +7% | +$575K | ﹤0.01% | 2062 |
|
|
2015
Q2 | $7.91M | Buy |
217,666
+1,348
| +0.6% | +$42.6K | ﹤0.01% | 2216 |
|
|
2015
Q1 | $6.24M | Buy |
216,318
+7,316
| +4% | +$204K | ﹤0.01% | 2372 |
|
|
2014
Q4 | $5.06M | Buy |
+209,002
| New | +$4.71M | ﹤0.01% | 2502 |
|
Other funds holding PRAH
Northern Trust's PRAH Position: Q3 2021 in Review
Northern Trust sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 498,787 shares — an estimated $82.4M sold.
Northern Trust first reported a position in PRAH in Q4 2014 and held it in 27 quarters. The position peaked at $83.2M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Northern Trust reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Northern Trust sold 498,787 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $82.4M.
- Northern Trust first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 27 quarters.
- Northern Trust's PRA Health Sciences, Inc. position peaked at $83.2M in Q1 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Northern Trust's 13F filing for Q3 2021, filed 15 Nov 2021.